Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis (Multiple Letters) [9]

Lancet

Volumn 349, Issue 9066, 1997, Pages 1696-1698

  De Keyser, J ^a   Zwanikken, C ^a   Beck, R W ^a   Tremlett, H ^a   Barnes, D ^a   Hughes, R A C ^a   Reinhardt, C ^a   Reul, J M H ^a   Melms, A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; METHYLPREDNISOLONE; GLUCOCORTICOID; PREDNISOLONE;

DRUG BIOAVAILABILITY; DRUG COST; DRUG EFFICACY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; MULTIPLE SCLEROSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RELAPSE; ADULT; DISABILITY; FEMALE; MALE; NOTE; RECURRENT DISEASE; TREATMENT OUTCOME; ECONOMICS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; DEXAMETHASONE; DISABILITY EVALUATION; FEMALE; GLUCOCORTICOIDS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; MULTIPLE SCLEROSIS; RECURRENCE; TREATMENT OUTCOME; PREDNISOLONE; MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 0030946157     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)26023-X     Document Type: Letter

References (5)

1. L Durelli A Cocito A Riccio Highdose intravenous methylprednisolone in the treatment of multiple sclerosis. Clinical-immunologic correlations Neurology 36 1985 238 243
2. NG Milligan R Newcombe DAS Compston A double-blind controlled trial of high-dose methylprednisolone in patients with multiple sclerosis. 1: clinical effects J Neurol Neurosurg Psychiatry 50 1986 511 516
3. SM Alam T Kyriakides M Lawden PK Newman Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high-dose J Neurol Neurosurg Psychiatry 56 1993 1219 1220
4. D Barnes RAC Hughes RW Morris Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis Lancet 349 1997 902 906
5. F Barkhof C Polman Oral or intravenous methylprednisolone for acute relapses of multiple sclerosis Lancet 349 1997 893 894